<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36016385</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Persisting Smell and Taste Disorders in Patients Who Recovered from SARS-CoV-2 Virus Infection-Data from the Polish PoLoCOV-CVD Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1763</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14081763</ELocationID><Abstract><AbstractText>In the majority of cases, patients infected with the SARS-CoV-2 virus experience a complete resolution of symptoms within six weeks of acquiring the infection, but an increasing number of patients report persistent symptoms. This study aimed to analyse the prevalence of self-reported smell and/or taste disorders (STDs) in a group of convalescent patients after infection with the SARS-CoV-2 virus and to identify risk factors for the disease. The study included 2218 COVID-19 convalescents after both inpatient and outpatient treatment. The sample group was analysed with regard to chronic diseases, place of isolation and clinical symptoms occurring during COVID-19 along with their duration. The assessment also included the most common symptoms of COVID-19 and the severity of the disease course. A total of 98 patients reported persistent smell and taste disorders up to three months after the end of isolation (67.4% of men and 32.6% of women). The mean age of the participants was 53.8 &#xb1; 13.5 years (49.19 &#xb1; 14.68 in patients with an STD vs. 54.01 &#xb1; 13.44 in patients without an STD). The patients treated for COVID-19 at home (p &lt; 0.001) constituted almost the entire group of patients with persistent smell and taste disorders (97%). Among the patients with persistent smell and taste disorders, 57.1% suffered from at least one chronic condition (vs. 71.4% of patients without an STD). In patients with an STD, the number of symptoms per patient was higher than in the other group at 8.87 &#xb1; 3.65 (p = 0.018), while the most common clinical symptoms during the acute phase of COVID-19 were smell and taste disorders (84%) (p &lt; 0.001), significant weakness (70%), headache (60%), cough (55%), arthralgia (51%) (p = 0.034) and back muscle pain (51%). Based on the results obtained, the following conclusions were drawn: the risk of developing persistent smell and taste disorders after COVID-19 is greater in younger people with less comorbidities and a higher number of symptoms during the acute phase of COVID-19. The risk is associated with clinical symptoms occurring during the acute phase of COVID-19, i.e., smell and taste disorders and arthralgia. In addition, this risk is higher in patients receiving outpatient treatment for COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chudzik</LastName><ForeName>Micha&#x142;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8805-9688</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babicki</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7719-6959</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastalerz-Migas</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6600-2760</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapusta</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5082-3641</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiac Rehabilitation, Medical University of Lodz, 70-445 Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="Y">Taste Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistence</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">smell</Keyword><Keyword MajorTopicYN="N">smell and taste disorders</Keyword><Keyword MajorTopicYN="N">taste</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36016385</ArticleId><ArticleId IdType="pmc">PMC9416276</ArticleId><ArticleId IdType="doi">10.3390/v14081763</ArticleId><ArticleId IdType="pii">v14081763</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornuss D., Lange B., Schr&#xf6;ter N., Rieg S., Kern W., Wagner D. Anosmia in COVID-19 patients. Clin. Microbiol. Infect. 2020;26:1426&#x2013;1427. doi: 10.1016/j.cmi.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7242197</ArticleId><ArticleId IdType="pubmed">32447049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee L.E., Chan Y.F.Z., Teo N.W.Y., Cherng B.P.Z., Thien S.Y., Wong H.M., Wijaya L., Toh S.T., Tan T.T. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19. Eur. Arch. Otorhinolaryngol. 2020;277:2389&#x2013;2390. doi: 10.1007/s00405-020-05999-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05999-5</ArticleId><ArticleId IdType="pmc">PMC7180656</ArticleId><ArticleId IdType="pubmed">32328771</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Deiana G., Fois A.G., Pirina P., Madeddu G., De Vito A., Babudieri S., Petrocelli M., Serra A., Bussu F., et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42:1252&#x2013;1258. doi: 10.1002/hed.26204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26204</ArticleId><ArticleId IdType="pmc">PMC7267244</ArticleId><ArticleId IdType="pubmed">32342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated character-istics. Otolaryngol. Head. Neck Surg. 2020;163:114&#x2013;120. doi: 10.1177/0194599820929185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820929185</ArticleId><ArticleId IdType="pmc">PMC7240313</ArticleId><ArticleId IdType="pubmed">32423357</ArticleId></ArticleIdList></Reference><Reference><Citation>Huart C., Philpott C., Konstantinidis I., Altundag A., Whitcroft K., Trecca E., Cassano M., Rombaux P., Hummel T. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. 2020;58:623&#x2013;625. doi: 10.4193/Rhin20.251.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.251</ArticleId><ArticleId IdType="pubmed">32812014</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A., Pezzati L., Conti F., Bernacchia D., Siano M., Oreni L., Rusconi S., Gervasoni C., Ridolfo A.L., Rizzardini G., et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: A cross-sectional study. Clin. Infect. Dis. 2020;71:889&#x2013;890. doi: 10.1093/cid/ciaa330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopfenstein T., Zahra H., Kadiane-Oussou N.J., Lepiller Q., Royer P.-Y., Toko L., Gendrin V., Zayet S. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int. J. Infect. Dis. 2020;100:117&#x2013;122. doi: 10.1016/j.ijid.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7410813</ArticleId><ArticleId IdType="pubmed">32771635</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto D.B., Fornazieri M.A., Dib C., Di Francesco R.C., Doty R.L., Voegels R.L., Pinna F.D.R. Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample. Otolaryngol. Head Neck Surg. 2021;164:512&#x2013;518. doi: 10.1177/0194599820954825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820954825</ArticleId><ArticleId IdType="pmc">PMC7464054</ArticleId><ArticleId IdType="pubmed">32867582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye R., Chang C.W.D., Kazahaya K., Brereton J., Denneny I.J.C. COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol. Head Neck Surg. 2020;163:132&#x2013;134. doi: 10.1177/0194599820922992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820922992</ArticleId><ArticleId IdType="pubmed">32340555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo A., Bonato M., Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci. Lett. 2021;748:135694. doi: 10.1016/j.neulet.2021.135694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.135694</ArticleId><ArticleId IdType="pmc">PMC7883672</ArticleId><ArticleId IdType="pubmed">33600902</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S., Postma E.M., Boak D., Welge-Luessen A., Sch&#xf6;pf V., Mainland J.D., Martens J., Ngai J., Duffy V.B. Anosmia&#x2014;A clinical review. Chem. Senses. 2017;42:513&#x2013;523. doi: 10.1093/chemse/bjx025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjx025</ArticleId><ArticleId IdType="pmc">PMC5863566</ArticleId><ArticleId IdType="pubmed">28531300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Kim S.W., Kang M., Hwang S.H. Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID-19: A systematic review and meta-analysis. Clin. Otolaryngol. 2022;47:509&#x2013;515. doi: 10.1111/coa.13933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13933</ArticleId><ArticleId IdType="pmc">PMC9111649</ArticleId><ArticleId IdType="pubmed">35352483</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and taste dysfunction in patients with COVID-19: A systematic review and meta-analysis. Mayo Clin. Proc. 2020;95:1621&#x2013;1631. doi: 10.1016/j.mayocp.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocke J., Hopkins C., Philpott C.M., Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis. Clin. Otolaryngol. 2020;45:914&#x2013;922. doi: 10.1111/coa.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13620</ArticleId><ArticleId IdType="pmc">PMC7436734</ArticleId><ArticleId IdType="pubmed">32741085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hura N., Xie D.X., Choby G.W., Schlosser R.J., Orlov C.P., Seal S.M., Rowan N.R. Treatment of post-viral olfactory dysfunction: An evidence-based review with recommendations. Int. Forum Allergy Rhinol. 2020;10:1065&#x2013;1086. doi: 10.1002/alr.22624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22624</ArticleId><ArticleId IdType="pmc">PMC7361320</ArticleId><ArticleId IdType="pubmed">32567798</ArticleId></ArticleIdList></Reference><Reference><Citation>Regemorter V.V., Hummel T., Rosenzweig F., Mouraux A., Rombaux P., Huart C. Mechanisms linking olfactory impairment and risk of mortality. Front. Neurosci. 2020;14:140. doi: 10.3389/fnins.2020.00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00140</ArticleId><ArticleId IdType="pmc">PMC7046549</ArticleId><ArticleId IdType="pubmed">32153360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli P., Soler Z.M., Nguyen S.A., Muus J.S., Schlosser R.J. The association between olfaction and depression: A systematic review. Chem. Senses. 2016;41:479&#x2013;486. doi: 10.1093/chemse/bjw061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjw061</ArticleId><ArticleId IdType="pmc">PMC4918728</ArticleId><ArticleId IdType="pubmed">27170667</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto J.M., Wroblewski K.E., Kern D.W., Schumm P., McClintock M.K. Olfactory dysfunction predicts 5-year mortality in older adults. PLoS ONE. 2014;9:e107541. doi: 10.1371/journal.pone.0107541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0107541</ArticleId><ArticleId IdType="pmc">PMC4182669</ArticleId><ArticleId IdType="pubmed">25271633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Whitcroft K.L., Andrews P., Altundag A., Cinghi C., Costanzo R.M., Damm M., Frasnelli J., Gudziol H., Gupta N., et al. Position paper on olfactory dysfunction. Rhinology. 2017;54:1&#x2013;30. doi: 10.4193/Rhino16.248.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino16.248</ArticleId><ArticleId IdType="pubmed">29528615</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R. Handbook of Olfaction and Gustation. 3rd ed. Wiley-Blackwell; Malden, MA, USA: 2015.</Citation></Reference><Reference><Citation>Suzuki M., Saito K., Min W.-P., Vladau C., Toida K., Itoh H., Murakami S. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007;117:272&#x2013;277. doi: 10.1097/01.mlg.0000249922.37381.1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlg.0000249922.37381.1e</ArticleId><ArticleId IdType="pmc">PMC7165544</ArticleId><ArticleId IdType="pubmed">17277621</ArticleId></ArticleIdList></Reference><Reference><Citation>Bon L.S.-D., Konopnicki D., Pisarski N., Prunier L., Lechien J.R., Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur. Arch. Otorhinolaryngol. 2021;278:3113&#x2013;3117. doi: 10.1007/s00405-020-06520-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06520-8</ArticleId><ArticleId IdType="pmc">PMC7796691</ArticleId><ArticleId IdType="pubmed">33423106</ArticleId></ArticleIdList></Reference><Reference><Citation>Parma V., Ohla K., Veldhuizen M.G., Niv M.Y., Kelly C.E., Bakke A.J., Cooper K.W., Bouysset C., Pirastu N., Dibattista M., et al. More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem. Senses. 2020;45:609&#x2013;622. doi: 10.1093/chemse/bjaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa041</ArticleId><ArticleId IdType="pmc">PMC7337664</ArticleId><ArticleId IdType="pubmed">32564071</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K., Ezzat M., Cuevas M., Andrews P., Hummel T. The effect of intranasal sodium citrate on olfaction in post-infectious loss: Results from a prospective, placebo-controlled trial in 49 patients. Clin. Otolaryngol. 2017;42:557&#x2013;563. doi: 10.1111/coa.12789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.12789</ArticleId><ArticleId IdType="pubmed">27860366</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network, (SIGN) and the Royal College of General Practitioners (RCGP)  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE Guideline, No. 188.  [(accessed on 18 December 2020)];:35. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK567261/</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2021;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2020;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E., et al. PostCOVID19 Syndrome in Outpatients: A Cohort Study. J. Gen. Intern. Med. 2022;37:1943&#x2013;1952. doi: 10.1007/s11606-021-07242-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Locatello L.G., Trotta B., Bruno C., Trotta M., Maggiore G., Rasero L., Caini S., Gallo O. Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: An observational study. Int. Forum Allergy Rhinol. 2021;11:1689&#x2013;1693. doi: 10.1002/alr.22848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22848</ArticleId><ArticleId IdType="pmc">PMC8427029</ArticleId><ArticleId IdType="pubmed">34132052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Surda P., Whitehead E., Kumar B.N. Early recovery following new onset loss of sense of smell during the COVID-19 pandemic&#x2014;An observational cohort study. J. Otolaryngol.-Head Neck Surg. 2020;49:26. doi: 10.1186/s40463-020-00423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40463-020-00423-8</ArticleId><ArticleId IdType="pmc">PMC7196882</ArticleId><ArticleId IdType="pubmed">32366299</ArticleId></ArticleIdList></Reference><Reference><Citation>Reden J., Mueller A., Mueller C., Konstantinidis I., Frasnelli J., Landis B.N., Hummel T. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch. Otolaryngol. Head Neck Surg. 2006;132:265&#x2013;269. doi: 10.1001/archotol.132.3.265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.132.3.265</ArticleId><ArticleId IdType="pubmed">16549746</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L., Hopkins C., Petrocelli M., Lechien J., Cutrupi S., Salzano G., Chiesa-Estomba C., Saussez S., De Riu G. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021;59:21&#x2013;25. doi: 10.4193/Rhin20.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.515</ArticleId><ArticleId IdType="pubmed">33290446</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Living Guidance for Clinical Management of COVID-19: Living Guidance. World Health Organization (WHO); Geneva, Switzerland: Nov 23, 2021.</Citation></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta J., Ko&#x142;at D., Ka&#x142;uzi&#x144;ska &#x17b;., Mastalerz-Migas A., Jankowski P. Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study. J. Pers. Med. 2022;12:706. doi: 10.3390/jpm12050706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050706</ArticleId><ArticleId IdType="pmc">PMC9145629</ArticleId><ArticleId IdType="pubmed">35629132</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H., Kobayashi T., Miyama T., Suzuki A., Jung S.-M., Hayashi K., Kinoshita R., Yang Y., Yuan B., Akhmetzhanov A.R., et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) Int. J. Infect. Dis. 2020;94:154&#x2013;155. doi: 10.1016/j.ijid.2020.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.020</ArticleId><ArticleId IdType="pmc">PMC7270890</ArticleId><ArticleId IdType="pubmed">32179137</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G., Fabbris C., Polesel J., Cazzador D., Borsetto D., Hopkins C., Rizzo P.B. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020;323:2089&#x2013;2090. doi: 10.1001/jama.2020.6771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6771</ArticleId><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Borsetto D., Spinato G., Fabbris C., Menegaldo A., Gaudioso P., Nicolai P., Tirelli G., Da Mosto M.C., Rigoli R., et al. New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects. Eur. Arch. Otorhinolaryngol. 2020;277:2637&#x2013;2640. doi: 10.1007/s00405-020-06066-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06066-9</ArticleId><ArticleId IdType="pmc">PMC7245639</ArticleId><ArticleId IdType="pubmed">32449021</ArticleId></ArticleIdList></Reference><Reference><Citation>Home Care for Patients With COVID-19 Presenting with Mild Symptoms and Management of Their Contacts n.d.  [(accessed on 27 April 2020)].  Available online:  https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts.</Citation></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H., Asseo K., Karni N., Benjamini Y., Nir-Paz R., Muszkat M., Israel S., Niv M.Y. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: A cohort study in Israeli patients. Clin. Microbiol. Infect. 2021;27:769&#x2013;774. doi: 10.1016/j.cmi.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Von-Bartheld C.S., Hagen M.M., Butowt R. Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences. ACS Chem. Neurosci. 2020;11:2944&#x2013;2961. doi: 10.1021/acschemneuro.0c00460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00460</ArticleId><ArticleId IdType="pmc">PMC7571048</ArticleId><ArticleId IdType="pubmed">32870641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Faraji F., Bs D.P.P., Ostrander B.T., DeConde A.S. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int. Forum Allergy Rhinol. 2020;10:821&#x2013;831. doi: 10.1002/alr.22592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22592</ArticleId><ArticleId IdType="pmc">PMC7264572</ArticleId><ArticleId IdType="pubmed">32329222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Journe F., Hans S., Chiesa-Estomba C.M., Mustin V., Beckers E., Vaira L., Riu G.D., Hopkins C., Saussez S. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front. Med. 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Printza A., Katotomichelakis M., Valsamidis K., Metallidis S., Panagopoulos P., Panopoulou M., Petrakis V., Constantinidis J. Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity. J. Clin. Med. 2021;10:966. doi: 10.3390/jcm10050966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10050966</ArticleId><ArticleId IdType="pmc">PMC7957474</ArticleId><ArticleId IdType="pubmed">33801170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Polesel J., A Vaira L. Smell and taste dysfunction after COVID-19. BMJ. 2022;378:o1653. doi: 10.1136/bmj.o1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1653</ArticleId><ArticleId IdType="pubmed">35947733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T.J., Yu A.C., Lee J.T. Management of post-COVID-19 olfactory dysfunction. Curr. Treat. Options Allergy. 2022;9:1&#x2013;18. doi: 10.1007/s40521-021-00297-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-021-00297-9</ArticleId><ArticleId IdType="pmc">PMC8723803</ArticleId><ArticleId IdType="pubmed">35004126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Alanin M., Philpott C., Harries P., Whitcroft K., Qureishi A., Anari S., Ramakrishnan Y., Sama A., Davies E., et al. Management of new onset loss of sense of smell during the COVID-19 pandemic&#x2014;BRS Consensus Guidelines. Clin. Otolaryngol. 2021;46:16&#x2013;22. doi: 10.1111/coa.13636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13636</ArticleId><ArticleId IdType="pmc">PMC7461026</ArticleId><ArticleId IdType="pubmed">32854169</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelalim A.A., Mohamady A.A., Elsayed R.A., Elawady M.A., Ghallab A.F. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am. J. Otolaryngol. 2021;42:102884. doi: 10.1016/j.amjoto.2020.102884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102884</ArticleId><ArticleId IdType="pmc">PMC7836546</ArticleId><ArticleId IdType="pubmed">33429174</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekala K.R., Chandra R., Turner J.H. Efficacy of olfactory training in patients with olfactory loss: A systematic review and meta-analysis. Int. Forum Allergy Rhinol. 2016;6:299&#x2013;307. doi: 10.1002/alr.21669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21669</ArticleId><ArticleId IdType="pmc">PMC4783272</ArticleId><ArticleId IdType="pubmed">26624966</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A., Y&#x131;ld&#x131;r&#x131;m D., Sanli D.E.T., Cayonu M., Kandemirli S.G., Sanli A.N., Duz O.A., Saatci O. Olfactory Cleft Measurements and COVID-19-Related Anosmia. Otolaryngol. Head Neck Surg. 2021;164:1337&#x2013;1344. doi: 10.1177/0194599820965920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820965920</ArticleId><ArticleId IdType="pmc">PMC7554408</ArticleId><ArticleId IdType="pubmed">33045908</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., Annane D., Azevedo L.C.P., Berwanger O., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324:1330&#x2013;1341. doi: 10.1001/jama.2020.17023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattos-Silva P., Felix N.S., Silva P.L., Robba C., Battaglini D., Pelosi P., Rocco P.R.M., Cruz F.F. Pros and cons of corticosteroid therapy for COVID-19 patients. Respir. Physiol. Neurobiol. 2020;280:103492. doi: 10.1016/j.resp.2020.103492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103492</ArticleId><ArticleId IdType="pmc">PMC7351052</ArticleId><ArticleId IdType="pubmed">32659271</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi A., Mohammadbagheri E., Akbari Dilmaghani N., Bayat A.-H., Fathi M., Vakili K., Alizadeh R., Rezaeimirghaed O., Hajiesmaeili M., Ramezani M., et al. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem. Neurosci. 2020;11:1909&#x2013;1913. doi: 10.1021/acschemneuro.0c00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00249</ArticleId><ArticleId IdType="pubmed">32525657</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydzewski B., Pruszewicz A., Sulkowski W.J. Assessment of smell and taste in patients with allergic rhinitis. Acta Otolaryngol. 2000;120:323&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">11603799</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Lagier J.-C., Raoult D., Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin. Microbiol. Infect. 2021;27:931&#x2013;932. doi: 10.1016/j.cmi.2020.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.021</ArticleId><ArticleId IdType="pmc">PMC7784539</ArticleId><ArticleId IdType="pubmed">33418020</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer M.A., Elsherif H.S., Abdel-Hamid A.S., Elzayat S. Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study. Am. J. Otolaryngol. 2020;41:102725. doi: 10.1016/j.amjoto.2020.102725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102725</ArticleId><ArticleId IdType="pmc">PMC7489267</ArticleId><ArticleId IdType="pubmed">32979666</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: Prospective follow-up by phone interviews. Rheumatol. Int. 2021;41:1263&#x2013;1271. doi: 10.1007/s00296-021-04882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04882-8</ArticleId><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.S., Hichami A., Khan N.A. Obesity and COVID-19: Oro-Naso-Sensory Perception. J. Clin. Med. 2020;9:2158. doi: 10.3390/jcm9072158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9072158</ArticleId><ArticleId IdType="pmc">PMC7408951</ArticleId><ArticleId IdType="pubmed">32650509</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel Z.M., DelGaudio J.M., Wise S.K. Higher body mass index is associated with subjective olfactory dysfunction. Behav. Neurol. 2015;2015:675635. doi: 10.1155/2015/675635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/675635</ArticleId><ArticleId IdType="pmc">PMC4496469</ArticleId><ArticleId IdType="pubmed">26199458</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Tirelli G., Meloni P., Hopkins C., Madeddu G., De Vito A., Gardenal N., Valentinotti R., Tofanelli M., Borsetto D., et al. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant. Int. Forum Allergy Rhinol. 2022;3:1&#x2013;9. doi: 10.1002/alr.22995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22995</ArticleId><ArticleId IdType="pmc">PMC9082058</ArticleId><ArticleId IdType="pubmed">35286777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>